Hematologic Neoplasms Clinical Trial
Official title:
Physical Therapy as "Drug, Non-drug"
To date, studies published on multidimensional rehabilitation programs are addressed to
patients with different types of cancer and, frequently, these studies only include a limited
number of patients with blood neoplasms. So, there is no evidence of the effectiveness of
multidimensional rehabilitation programs in this particular category of patients. A
systematic review of the effectiveness of aerobic exercise alone, not associated with
therapeutic education, has recently been conducted in adult individuals with hematological
malignancies (reference 25386666). The review highlighted the effectiveness of physical
activity on the quality of life of the target population. However, the medium and long term
effects that physical exercise have on other clinically relevant endpoints, such as fatigue,
psychological distress, and physical performance level, remain to be clarified. Thus, it is
important to investigate the effectiveness of multidimensional interventions that integrate
physical activity to therapeutic education targeted at the specific needs of individuals with
blood neoplasm.
The aim of this study is to evaluate, in blood cancer patients, the feasibility of a
therapeutic education program associated with physical activity, and to verify its effect by
a long-term follow-up.
This is a randomized controlled pilot study • Control Group will be offered usual care (UC),
which includes two sessions of therapeutic education delivered in small groups. In these
educational sessions, patients are provided with useful information on communication
strategies, problem solving strategies, recognition and management of symptoms and the
management of any aids/orthoses provided in everyday life, etc. In the meetings, it will be
emphasized the importance of maintaining an active lifestyle as much as possible by
encouraging involvement in physical activity even during the cancer treatment period.
Written information material that summarizes the concepts addressed during group meetings
will be provided.
• Intervention group will be offered therapeutic education as described for the control
group, plus 6 individual sessions of therapeutic education and physical activity (ETAF). The
6 individual session will be held by a physiotherapist dedicated to the study, on a weekly /
bi-weekly basis, according to the objectives set and the needs of the patient.
In these sessions, the topics already discussed in group will be deepened, personalizing them
according to the patient's characteristics. Furthermore, personalized physical activity is
planned, taking into account the context of execution, the clinical condition and the
patient's preferences. Patients will be trained to build an action plan aimed at self-plan
physical activities and a diary will be provided to monitor the physical activity carried out
autonomously.
Written information material that summarizes the concepts addressed during group and
individual sessions will be provided.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03483194 -
Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)
|
Phase 2/Phase 3 | |
Recruiting |
NCT03735992 -
Mind-body Medicine for Patients With Malignant Hematological Diseases
|
N/A | |
Recruiting |
NCT04959175 -
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04275154 -
Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy
|
||
Terminated |
NCT00957580 -
Trial of Pimasertib in Hematological Malignancies
|
Phase 2 | |
Completed |
NCT00997386 -
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States
|
Phase 2 | |
Completed |
NCT00389428 -
Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
|
Phase 1 | |
Completed |
NCT02193880 -
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)
|
N/A | |
Recruiting |
NCT00071045 -
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
|
||
Not yet recruiting |
NCT05054231 -
Immunological Profile for Patients Treated With CAR-T Cells
|
N/A | |
Completed |
NCT02650791 -
Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study
|
Phase 3 | |
Completed |
NCT01362179 -
National Marrow Donor Program Long-Term Donor Follow-Up
|
||
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Terminated |
NCT03648372 -
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System
|
Phase 1/Phase 2 | |
Recruiting |
NCT03320915 -
Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT
|
Phase 2 | |
Recruiting |
NCT06422533 -
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
|
N/A | |
Terminated |
NCT02895529 -
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
|
Phase 4 | |
Active, not recruiting |
NCT03680092 -
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
|
Phase 2 | |
Recruiting |
NCT03083327 -
Prophylactic Early PN in HPT/BMT
|
N/A | |
Recruiting |
NCT03743480 -
Early Palliative Care and Hematological Cancer Patients
|
N/A |